Jaguar Animal Health, Inc. (JAGX) vs Xenetic Biosciences, Inc. (XBIO)

Jaguar Animal Health, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.5M and $4.2M). Xenetic Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against 33.3%. Xenetic Biosciences, Inc. has the higher net margin (−75.9% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 19 metrics below, Xenetic Biosciences, Inc. leads on 11 and Jaguar Animal Health, Inc. on 8.

Valuation

Metric JAGX XBIO Biotechnology median
P/E 0.00 n/m 8.58
P/S 0.00 1.34 10.29
P/B 0.02 0.72 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.14 0.37 0.67
EV/Sales (0.11) (0.30) 9.89
Earnings yield 82,577.65% (61.05%) (31.56%)
Free cash flow yield (6,233.72%) (53.01%) (23.42%)

Profitability

Metric JAGX XBIO Biotechnology median
Gross margin 82.31% 100.00% 65.77%
Operating margin (93.10%) (81.01%) 0.00%
Net margin (188.46%) (75.90%) 0.00%
Free cash flow margin (24.03%) (70.93%) 0.00%
Return on equity (1,125.38%) (47.05%) (54.09%)
Return on assets (127.14%) (40.17%) (47.78%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX XBIO Biotechnology median
Revenue growth (TTM) 135.52% 33.30% 5.83%
EPS growth (last fiscal year) 82.42% 38.52% 29.36%
Revenue growth, 5-year CAGR 4.17% 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX XBIO Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 7.43 4.80
Net debt to EBITDA (0.17) 2.78 0.97

Dividend

Metric JAGX XBIO Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric JAGX XBIO Biotechnology median
Market cap 4.18m 4.52m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack